3 Under-the-Radar Healthcare Companies Travere Therapeutics (NASDAQ:TVTX) reported second-quarter results marked by record ...

SAN DIEGO (AP) — SAN DIEGO (AP) — Travere Therapeutics, Inc. (TVTX) on Tuesday reported a loss of $34.8 million in its second quarter. The San Diego-based company said it had a loss of 37 cents per ...

Travere Therapeutics, Inc. (Nasdaq: TVTX) today reported its second quarter 2026 financial results and provided a corporate update. “With an exceptional second quarter, Travere has entered a new ...

Q2 reframed FILSPARI as a two-indication commercial story, with management emphasizing it was "the first quarter with FILSPARI commercially available across both IgA nephropathy and FSGS" (President, ...

Travere Therapeutics, Inc. ( TVTX) Q2 2026 Earnings Call August 4, 2026 4:30 PM EDT Good morning, and welcome to Travere Therapeutics Second Quarter 2026 Financial Results Conference Call. Today's ...

Travere Therapeutics Inc. TVTX shares surged 13.44% to $63.55 in after-hours trading on Tuesday after the biopharmaceutical ...

Trent Harrison, the founder of Ransomed Bodies Training, is proud to announce the official release of his highly anticipated ...

Here's a quick look at the stocks that are seeing gap-up moves before the bell on Wednesday. U.S. stock index futures rose on Wednesday as Wall Street looked to continue its upbeat mood a day after a ...

As awareness of the importance of workplace mental health continues to grow, more BC municipalities are expanding access to mental health care by adding Registered Clinical Counsellors (RCCs) to their ...

The now completed VISIONARY study marks another milestone in Otsuka’s rolling sBLA submission.

(SHOP) was up 25.3% in pre-market trading, and Travere Therapeutics Inc. (TVTX) was up 12.7%.